IP Library Granted Patent US 11,954,851
Granted Patent B2
US 11,954,851 · App. 17/364,773 · Granted Apr 9, 2024

Image-based disease diagnostics using a mobile device

Inventors: Ivan Krastev Dimov (Union City, CA); Frank B. Myers, III (Richmond, CA); John Robert Waldeisen (Berkeley, CA); Debkishore Mitra (Fremont, CA)
Assignee: Pfizer Inc.
G06T7/0012A61B5/0059A61B5/1032A61B5/6898A61B5/7282A61B5/742G06T7/60G06T7/90G06T7/97G16B40/00G16H10/40G16H30/40G16H50/20A61B2576/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,954,851
App. No.
17/364,773
Granted
Apr 9, 2024
Kind
B2
Abstract

A diagnostic system performs disease diagnostic tests using at least an optical property modifying device and a mobile device. A user provides a biological sample from a patient to the optical property modifying device that reacts with a reagent in one or more reaction chambers of the device. The user captures one or more images of the one or more reaction chambers using an optical sensor of the mobile device. The diagnostic system can determine a quality level of the images based on factors such as skew, scale, focusing, shadowing, or white-balancing. Based on an analysis of the captured image, the diagnostic system can determine a test result of a disease diagnostic test for the patient. The diagnostic system may communicate the test result, as well as instructions for the disease diagnostic test, to the user via the mobile device.

Claims (18)

1. A system comprising:

an optical property modifying device for image-based diagnostic tests, comprising: (i) a reaction chamber, configured to react a biological sample with an optical property modifying reagent, wherein a reaction modifies an optical property of the optical property modifying reagent, and (ii) an electronic display;

a diagnostic server; and

a mobile device comprising a non-transitory computer readable storage medium having instructions encoded thereon that, when executed by a processor of the mobile device, cause the processor to:

receive at least one image of the optical property modifying device captured by an optical sensor of the mobile device; and

provide a test result for the nucleic acid disease diagnostic test for display on an electronic display of the mobile device;

wherein the processor of the mobile device or the diagnostic server is configured to:

determine that the image of the set of one or more images shows a known geometric characteristic or a known color characteristic associated with the optical property modifying device; and

determine the test result for the diagnostic test based at least in part on the image.

2. The system of claim 1 , wherein the processor comprises a user interface comprising one or more alignment markers configured to overlay a field of view to assist a user of the mobile device in aligning the mobile device for capturing the image.

3. The system of claim 2 , wherein the one or more alignment markers are a semi-transparent graphic of the optical property modifying device; (ii) one or more markers that correspond to a graphic of an element of the optical property modifying device; or

(iii) a line that should be aligned with an edge of the optical property modifying device.

4. The system of claim 1 , wherein the processor of the mobile device or the diagnostic server is configured to determine the test result for the nucleic acid disease diagnostic test by classifying each pixel comprising a reaction chamber within the selected one or more images as falling within one of three color ranges such that: (1) if a plurality of pixels falls within the first color range, a negative diagnosis is determined; (2) if a plurality of pixels falls within the second color range, a positive diagnosis is determined; and (3) if a plurality of pixels falls within the third color range, an undetermined diagnosis is determined.

5. The system of claim 1 , wherein the non-transitory computer readable storage medium has further instructions that when executed by the processor cause the processor to:

receive a geographical location of the mobile device from a GPS processor of the mobile device; and

store the geographical location and a timestamp of the geographical location with the test result.

6. The system of claim 5 , wherein determining the test result is further based on at least one of the geographical location and the timestamp.

7. The system of claim 1 , wherein the non-transitory computer readable storage medium has further instructions that when executed by the processor cause the processor to utilize white balancing based on the known color of the optical property modifying device to determine lighting conditions of the image and adjust color of the image.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2023
From: LUCIRA HEALTH, INC.
To: PFIZER INC.
Reel/Frame 064784/0948 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2021
From: DIMOV, IVAN KRASTEV; MYERS, FRANK B., III; WALDEISEN, JOHN ROBERT; MITRA, DEBKISHORE
To: DIASSESS INC.
Reel/Frame 057041/0535 →
CHANGE OF NAME Recorded Jul 30, 2021
From: DIASSESS INC.
To: LUCIRA HEALTH, INC.
Reel/Frame 057047/0110 →
Continuity (3)
Continuation 16155829 · Oct 9, 2018
Continuation In Part 15481349 · Apr 6, 2017
Related Publication 20220108439A1 · Apr 7, 2022